TRPV1 and Alzheimer disease: In summary, our study demonstrates that genetic or pharmacological activation of TRPV1 not only improves hippocampal LTP and memory but also reduces neuritic plaques in mouse model of AD, suggesting a potential therapeutic role of TRPV1 for learning and memory deficits associated with both patients with AD and aged populations.